SCA
MYOK

Secor Capital Advisors’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Secor Capital Advisors’s Portfolio MYOK Stock Details MYOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-23,847
Closed -$1.02M – 625
2017
Q3 		$1.02M Buy
+23,847
New +$761K 0.1% 270

Other funds holding MYOK

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
TGI
TRV GP II Boston, Massachusetts $1.34M AUM 67.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Secor Capital Advisors's MYOK Position: Q4 2017 in Review

Secor Capital Advisors sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2017, closing a stake of 23,847 shares — an estimated $1.02M sold.

Secor Capital Advisors first reported a position in MYOK in Q3 2017 and held it in 1 quarter. The position peaked at $1.02M in Q3 2017. 121 funds tracked by Wall St. Rank hold MYOK as of Q4 2017.

  • Secor Capital Advisors reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2017 after selling out during the quarter.
  • Secor Capital Advisors sold 23,847 MyoKardia, Inc. Common Stock shares in Q4 2017, an estimated $1.02M.
  • Secor Capital Advisors first reported a position in MyoKardia, Inc. Common Stock in Q3 2017 and held it in 1 quarter.
  • Secor Capital Advisors's MyoKardia, Inc. Common Stock position peaked at $1.02M in Q3 2017.
  • 121 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2017.

Based on Secor Capital Advisors's 13F filing for Q4 2017, filed 14 Feb 2018.